A Phase 3 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study of S5G4T-1 in the Treatment of Papulopustular Rosacea
Phase of Trial: Phase III
Latest Information Update: 29 Jun 2018
At a glance
- Drugs Benzoyl peroxide (Primary)
- Indications Rosacea
- Focus Registrational; Therapeutic Use
- Sponsors Sol-Gel Technologies
- 18 Jun 2018 According to a Sol-Gel Technologies media release, the company expects to report top-line data from this trial in 2019.
- 18 Jun 2018 According to a Sol-Gel Technologies media release, status changed from not yet recruiting to recruiting.
- 26 Mar 2018 According to the Sol-Gel Technologies media release, this trial is expected to start in the first half of 2018.